| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.57B | 25.07B | 23.96B | 25.75B | 31.96B | 30.86B |
| Gross Profit | 4.86B | 6.37B | 5.27B | 3.56B | 9.65B | 9.14B |
| EBITDA | 1.62B | 3.06B | 1.84B | 571.96M | 5.62B | 5.21B |
| Net Income | -2.41B | 1.16B | -2.36B | -4.30B | 2.18B | 3.16B |
Balance Sheet | ||||||
| Total Assets | 33.51B | 35.80B | 33.61B | 36.64B | 37.05B | 34.77B |
| Cash, Cash Equivalents and Short-Term Investments | 9.52B | 9.63B | 9.43B | 9.23B | 8.57B | 10.22B |
| Total Debt | 13.50B | 13.04B | 12.98B | 11.52B | 7.88B | 5.84B |
| Total Liabilities | 16.54B | 17.04B | 16.21B | 16.08B | 12.45B | 12.04B |
| Stockholders Equity | 16.97B | 18.76B | 17.40B | 20.55B | 24.59B | 22.73B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.69B | -521.13M | -2.31B | -3.19B | 139.43M |
| Operating Cash Flow | 0.00 | 3.13B | 3.36B | 1.93B | 1.29B | 1.75B |
| Investing Cash Flow | 0.00 | -2.36B | -3.76B | -4.55B | -4.57B | -1.61B |
| Financing Cash Flow | 0.00 | -953.56M | 442.36M | 2.71B | 1.51B | -2.06B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥192.07B | -20.01 | 1.86% | 0.76% | -14.55% | 100.23% | |
67 Neutral | ¥28.57B | 14.10 | ― | 3.98% | 4.66% | ― | |
67 Neutral | ¥6.58T | 14.32 | -2.51% | 1.31% | 6.68% | -106.55% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
53 Neutral | ¥1.65T | -1.70 | -4.26% | 2.30% | 7.29% | -216.41% | |
52 Neutral | ¥13.04B | -5.95 | ― | 1.86% | 11.06% | -804.16% | |
47 Neutral | ¥175.74B | -15.00 | ― | ― | -34.08% | -122.57% |